drugset / Trial / NCT02559440

Mometasone Furoate and Oxymetazoline in the Treatment of Adenoid Hypertrophy

NCT02559440

Phase 4 Completed 240 enrolled Guangzhou Women and Children's Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine the effect of MF/OXY in the treatment of adenoid hypertrophy children with severe allergic rhinitis.

Timeline

Start
2014-02
Primary completion
2015-02
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mometasone furoate Other / unclassified 50 ug Intranasal
Comparator Oxymetazoline Other / unclassified 0.05 % Intranasal

Indications